Related Stories
21 de November de 2023
Trial on LRRK2 mutation in Parkinson’s disease is about to be completed. Our Clinical Trials…
Posted in: Uncategorised
16 de January de 2023
On Epiphany, the U.S. Food and Drug Administration approved a new drug for early-stage Alzheimer’s…
3 de June de 2021
The General University Hospital of Catalonia is the first recognized center in Europe to evaluate…
Posted in: Alzeimer, Uncategorised
22 de July de 2020
The FDA has approved the use of sublingual apomorphine (KYNMOBI) in motor blocks, in Parkinson’s…
Posted in: Parkinson, Uncategorised
12 de December de 2019
5 de November de 2019
The Pasqual Maragall Foundation develops a method based on magnetic resonance imaging It allows to…
Posted in: Alzeimer, Uncategorised
19 de July de 2019
We have been selected to evaluate an innovative therapy in this terrible disease. We will…
Posted in: Uncategorised